✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
We discuss the potential role of autoantibodies in the development of LM.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Lupus myelitis (LM) is a rare but serious complication of systemic lupus erythematosus (SLE).
📊
Key Findings & Data:In 2009, Birnbaum et al. suggested that LM could be classified into two subtypes, namely gray and white matter myelitis, based on neurological examination findings.
💡
Conclusion & Impact:We discuss the potential role of autoantibodies in the development of LM.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters
Abstract
Lupus myelitis (LM) is a rare but serious complication of systemic lupus erythematosus (SLE). In 2009, Birnbaum et al. suggested that LM could be classified into two subtypes, namely gray and white matter myelitis, based on neurological examination findings. Here we describe three cases of this disorder, one with signs of white matter dysfunction and two with signs of gray matter dysfunction. We discuss the potential role of autoantibodies in the development of LM.
🔖
Cite This Article
OİWA, H., YAMABE, T., KAWASHİMA, M., MAETANİ, Y., AGARİ, D., YAMAWAKİ, T., SUGİYAMA, E. (2022). A report of three cases with lupus myelitis. European Journal of Rheumatology, Cilt: 4 - Sayı: 2, 148–150. https://ajindex.com/articles/511756